Uppsala Reports editor
@UMCGlobalSafety
Disproportionality analyses are a mainstay of pharmacovigilance research, but despite their prevalence are often misinterpreted, misunderstood, and sometimes misguided.
This is why Michele Fusaroli, Daniele Sartori, and their colleagues published the READUS-PV statement, the first-ever guide to reporting disproportionality analyses. Tune in to find out more about these guidelines and how they came to be, the history and overall impact of guidelines in pharmacological research, and what it means to publish "good" pharmacovigilance science.
Subscribe by visiting the Drug Safety Matters website.